These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4280140)

  • 61. [Antinuclear factors. II. Clinical and immunopathological significance].
    Peltier AP
    Presse Med (1893); 1970 Nov; 78(50):2241-4. PubMed ID: 4098987
    [No Abstract]   [Full Text] [Related]  

  • 62. [Nucleic acids and reactive glycoproteins of the blood in systemic lupus erythematosus].
    Volkova ZI
    Ter Arkh; 1979; 51(8):103-9. PubMed ID: 92065
    [No Abstract]   [Full Text] [Related]  

  • 63. [Interaction of DNA-hydrolyzing autoantibodies with low molecular weight substrates].
    Shchurov DV; Makarevich OI; Lopaeva OA; Buneva VN; Nevinskiĭ GA; Gabibov AG
    Dokl Akad Nauk; 1994 Jul; 337(3):407-10. PubMed ID: 7951031
    [No Abstract]   [Full Text] [Related]  

  • 64. [Blood DNA- and RNA-binding activity in systemic lupus erythematosus and other collagenoses in children].
    Kvachadze IM; Adamashvili IM; Makarova OV; Sheliia NV
    Pediatriia; 1980; (9):30-2. PubMed ID: 6159570
    [No Abstract]   [Full Text] [Related]  

  • 65. [Labilization of DNA structure of peripheral blood leukocytes in patients with systemic lupus erythematosus].
    Iliushina NA; Reshetniak TM; Moskalëva EIu; Bezobrazova LV; Alekberova ZS
    Vestn Ross Akad Med Nauk; 1993; (9):36-8. PubMed ID: 7510182
    [No Abstract]   [Full Text] [Related]  

  • 66. Is autoimmunity a common denominator in immune complex diseases?
    Lewis EJ; Roberts JL
    Lancet; 1980 Jan; 1(8161):178-80. PubMed ID: 6101634
    [TBL] [Abstract][Full Text] [Related]  

  • 67. New Perspectives in Rheumatology: Biomarkers as Entry Criteria for Clinical Trials of New Therapies for Systemic Lupus Erythematosus: The Example of Antinuclear Antibodies and Anti-DNA.
    Pisetsky DS; Rovin BH; Lipsky PE
    Arthritis Rheumatol; 2017 Mar; 69(3):487-493. PubMed ID: 27899010
    [No Abstract]   [Full Text] [Related]  

  • 68. Clinical connections: assays and assignment.
    Bell DA; Smeenk RJ
    Lupus; 1997; 6(3):305-6. PubMed ID: 9296772
    [No Abstract]   [Full Text] [Related]  

  • 69. The discovery of autoantibody to deoxyribonucleic acid.
    Holman H
    Lupus; 2011 Apr; 20(5):441-2. PubMed ID: 21339243
    [No Abstract]   [Full Text] [Related]  

  • 70. Activation of blood clotting in patients with systemic lupus erythematosus. Relationship to disease activity.
    Hardin JA; Cronlund M; Haber E; Bloch KJ
    Am J Med; 1978 Sep; 65(3):430-6. PubMed ID: 309726
    [No Abstract]   [Full Text] [Related]  

  • 71. Lessons learned from man's best friend: canine systemic lupus erythematosus.
    Lewis RM
    Int J Dermatol; 1977 Mar; 16(2):117-9. PubMed ID: 191416
    [No Abstract]   [Full Text] [Related]  

  • 72. Auto-antibodies to pituitary tissue and pituitary hormones in a case of systemic lupus erythematosus.
    Jonsson J; Havermark G; Olhagen B
    Acta Rheumatol Scand; 1969; 15(1):21-8. PubMed ID: 4902687
    [No Abstract]   [Full Text] [Related]  

  • 73. Heberden oration 1986. Complement--friend or foe?
    Lachmann PJ
    Br J Rheumatol; 1987 Dec; 26(6):409-15. PubMed ID: 2961393
    [No Abstract]   [Full Text] [Related]  

  • 74. Antinuclear factors in nephrotic syndrome secondary to systemic lupus erythematosus and in leprosy.
    Azoury FJ; Gum OB
    Am J Med Sci; 1967 Jun; 253(6):661-6. PubMed ID: 4165222
    [No Abstract]   [Full Text] [Related]  

  • 75. Systemic lupus erythematosus - a state of hyperinterferonemia?
    Weinberger A; Aderka D; Pinkhas J
    Med Hypotheses; 1982 Oct; 9(4):369-73. PubMed ID: 6185828
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Specificity of antibodies against double-stranded D.N.A. in autoimmune disorders.
    Monier JC; Perraud M; Chevallier P; Sepetjan M; Trepo C
    Lancet; 1978 May; 1(8071):989-90. PubMed ID: 76916
    [No Abstract]   [Full Text] [Related]  

  • 77. Immune responses to DNA in normal and aberrant immunity.
    Pisetsky DS
    Immunol Res; 2000; 22(2-3):119-26. PubMed ID: 11339349
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Antinuclear factors and the protein spectrum in disseminated lupus erythematosus].
    MANDEMA E; POLLAK VE; KARK RM
    Ned Tijdschr Geneeskd; 1962 Jan; 106():143-5. PubMed ID: 14469209
    [No Abstract]   [Full Text] [Related]  

  • 79. [DNA level in the nuclei of peripheral blood lymphocytes of children with systemic lupus erythematosus].
    Ptashekas RS; Sakene VE; Zhukene GI
    Pediatriia; 1987; (12):28-31. PubMed ID: 3444694
    [No Abstract]   [Full Text] [Related]  

  • 80. [ERYTHEMATOSUS AND AUTOIMMUNITY].
    YAMAGUCHI S; KOMIYA M
    Arerugi; 1964 May; 13():329-34. PubMed ID: 14148061
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.